Description
Methylprednisolone Acetate 80 mg/mL
Dosage Form: Injectable Suspension
Pack Size: 1 × 2 mL Vial
Manufacturer: Sarian Healthcare
Composition
ARIPRIDE-80 INJ contains:
- Methylprednisolone Acetate – 80 mg/mL
Methylprednisolone Acetate is a glucocorticoid corticosteroid with potent anti-inflammatory and immunomodulatory activity. It is used under medical supervision for selected inflammatory, allergic, rheumatic, dermatological, and other corticosteroid-responsive conditions.
The specific indication, route of administration, dosage, and treatment duration depend on the patient’s clinical condition and the prescribed treatment plan.
What Is ARIPRIDE-80 INJ Used For?
ARIPRIDE-80 INJ contains Methylprednisolone Acetate 80 mg/mL, a corticosteroid used for selected inflammatory and immune-mediated conditions when an injectable corticosteroid is clinically appropriate.
Methylprednisolone Acetate may be used under professional medical supervision for selected:
- Inflammatory conditions
- Allergic disorders
- Rheumatic conditions
- Dermatological conditions
- Localized inflammatory conditions
- Other corticosteroid-responsive conditions
Depending on the formulation and prescribed route, methylprednisolone acetate may have systemic, intra-articular, soft-tissue, or intralesional applications.
The exact indication and route must be determined by a qualified healthcare professional. ARIPRIDE-80 INJ should not be self-administered.
Key Ingredient and Its Function
Methylprednisolone Acetate 80 mg/mL
Drug Class: Glucocorticoid corticosteroid
Therapeutic Category: Anti-inflammatory and immunosuppressive therapy
Strength: 80 mg/mL
Dosage Form: Injectable formulation
Primary Function:
Helps reduce inflammatory and immune-mediated responses.
Pharmacological Role:
Synthetic glucocorticoid acting through intracellular glucocorticoid receptors.
Methylprednisolone Acetate is a corticosteroid derivative with anti-inflammatory, antiallergic, and immunomodulatory properties. Its effects arise from regulation of inflammatory gene expression and suppression of multiple inflammatory pathways.
Key Benefits of ARIPRIDE-80 INJ
- Potent anti-inflammatory activity – Helps suppress excessive inflammatory responses in appropriate corticosteroid-responsive conditions.
- Immunomodulatory action – Reduces excessive immune activity associated with selected inflammatory disorders.
- Broad clinical applicability – Methylprednisolone Acetate injectable formulations have established uses across selected rheumatic, allergic, dermatological, and localized inflammatory conditions.
- Defined 80 mg/mL strength – Provides a clearly specified concentration for professional administration according to the prescribed clinical requirement.
- Injectable corticosteroid presentation – Suitable for administration by qualified healthcare professionals when an injectable corticosteroid is clinically indicated.
- Multiple clinical applications – Depending on the formulation and prescribed route, methylprednisolone acetate can be used for selected systemic, intra-articular, soft-tissue, or intralesional indications.
How Does Methylprednisolone Acetate 80 mg/mL Work?
Methylprednisolone Acetate acts as a synthetic glucocorticoid.
After administration, methylprednisolone enters cells and binds to intracellular glucocorticoid receptors. The resulting receptor complex influences gene transcription and modifies the production of proteins involved in inflammatory and immune responses.
This action can:
- Reduce the formation and release of inflammatory mediators
- Decrease immune-cell activity
- Suppress tissue inflammation
- Reduce inflammatory swelling
- Modulate excessive immune responses
The Methylprednisolone Acetate mechanism of action operates at multiple levels of the inflammatory pathway rather than targeting a single inflammatory mediator.
The clinical effect and duration depend on the dose, route of administration, formulation, treated condition, and individual patient factors.
Important Route Consideration
Methylprednisolone acetate injectable suspension is not appropriate for every injection route.
The supplied product information specifically states that it must not be administered intrathecally. Serious neurological events have also been reported following epidural corticosteroid administration.
The route of administration must therefore be selected according to approved product information and qualified medical judgment.
Directions for Use
ARIPRIDE-80 INJ should be administered only by a qualified healthcare professional.
- The route of administration must be selected according to the approved product information, clinical indication, and physician’s instructions.
- Methylprednisolone Acetate injectable suspension may have different clinical applications depending on the prescribed route, including selected intramuscular, intra-articular, soft-tissue, or intralesional uses.
- It must not be administered intrathecally.
- Do not self-inject or allow administration by an unqualified person.
- The dose and frequency depend on the disease, severity, route, treatment response, and patient-specific factors.
- Appropriate sterile injection technique and correct placement are essential to reduce injection-related complications.
- Do not discontinue prolonged corticosteroid therapy abruptly unless directed by the treating physician.
Dosage and treatment duration should be determined by the treating physician according to the patient’s clinical condition and response to therapy.
Possible Side Effects
Not every patient experiences adverse effects. The risk depends on dose, duration, route, underlying disease, and individual susceptibility.
Common or Possible Side Effects
- Injection-site pain or irritation
- Skin or subcutaneous tissue changes at the injection site
- Increased appetite
- Indigestion or gastrointestinal discomfort
- Headache
- Fluid retention or swelling
- Increased blood glucose
- Mood or sleep changes
Important Adverse Reactions
Systemic corticosteroid exposure can cause:
- Hypertension
- Hyperglycemia
- Electrolyte changes
- Increased susceptibility to infection
- Adrenal suppression
- Cushingoid effects
- Osteoporosis
- Impaired wound healing
- Ocular complications
Serious hypersensitivity reactions, including anaphylaxis, can occur rarely.
Injection-site skin or subcutaneous atrophy can occur if the medicine is improperly deposited into or around the skin.
Seek immediate medical attention for severe allergic reactions, serious infection symptoms, severe weakness, significant changes in vision, severe mood or behavioural changes, or other serious or persistent reactions.
Safety Information
Medical Supervision
Methylprednisolone Acetate 80 mg injection should only be administered under qualified medical supervision.
Infections
Corticosteroids can suppress immune responses and may increase susceptibility to infections or mask signs of infection.
Systemic fungal infections are a contraindication except in specific localized joint circumstances described in professional labeling.
Hypersensitivity
Do not use in patients with known hypersensitivity to Methylprednisolone Acetate or formulation components.
Injection Route
Methylprednisolone Acetate injectable suspension must not be administered intrathecally.
Serious neurological events have also been reported following epidural corticosteroid administration.
Kidney Impairment
Patients with renal impairment require appropriate clinical assessment because corticosteroids can influence fluid, electrolyte, and metabolic balance.
Liver Impairment
Inform the treating physician about significant liver disease.
Diabetes
Corticosteroids can increase blood glucose and may affect diabetic treatment requirements.
Hypertension and Heart Disease
Corticosteroids may cause sodium and fluid retention and can increase blood pressure in susceptible patients.
Gastrointestinal Disease
Use caution in patients with relevant gastrointestinal disorders, including ulcer-related conditions.
Pregnancy
Use during pregnancy only when the treating physician considers the expected benefit appropriate.
Breastfeeding
Consult a healthcare professional before use during lactation.
Pediatric Patients
Prolonged corticosteroid exposure may affect growth and development. Pediatric use requires appropriate specialist supervision.
Elderly Patients
Consider increased susceptibility to osteoporosis, hypertension, diabetes, infection, and other corticosteroid-related effects.
Drug Interactions
Inform the healthcare professional about all medicines being used, including:
- Other corticosteroids
- Immunosuppressants
- Anticoagulants
- Antidiabetic medicines
- Medicines affecting electrolyte balance
Vaccination
Corticosteroid-induced immunosuppression can affect vaccination considerations. Vaccination decisions should be made by the treating healthcare professional.
Driving
If dizziness, visual disturbance, mood changes, or other symptoms affect alertness, patients should avoid driving or operating machinery.
Storage
Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children. Follow the storage instructions printed on the product packaging.
Storage Instructions
- Store in a cool, dry place.
- Keep away from direct sunlight and moisture.
- Keep out of reach of children.
- Follow the storage instructions printed on the product packaging.
- Handle and store the injectable formulation according to the manufacturer’s instructions.
Sarian Healthcare – Pharmaceutical Company in Gujarat
Sarian Healthcare is a pharmaceutical company in Gujarat with a diverse portfolio of pharmaceutical products across multiple therapeutic categories and dosage forms.
ARIPRIDE-80 INJ is part of Sarian Healthcare’s pharmaceutical product portfolio, providing Methylprednisolone Acetate 80 mg/mL in an injectable formulation for professional healthcare use.
The company serves healthcare professionals, hospitals, distributors, stockists, pharmacies, clinics, and pharmaceutical procurement teams.
Pharmaceutical Company in Ahmedabad and Changodar
Sarian Healthcare is part of the pharmaceutical ecosystem serving Ahmedabad, Changodar, and other pharmaceutical markets across Gujarat.
The company maintains a pharmaceutical product portfolio covering multiple therapeutic categories and dosage forms to support healthcare and pharmaceutical supply requirements.
Pharmaceutical Manufacturers in Gujarat
Gujarat is an important pharmaceutical manufacturing and supply hub in India.
Sarian Healthcare contributes to this pharmaceutical ecosystem through its portfolio of pharmaceutical formulations and healthcare products, supporting professional healthcare and pharmaceutical supply channels.
Generic Medicine Company in Gujarat
Sarian Healthcare maintains a broad pharmaceutical portfolio designed to support healthcare requirements across multiple therapeutic segments.
Its products are supplied through appropriate healthcare and pharmaceutical distribution channels for professional use.
Healthcare Companies in Ahmedabad
Ahmedabad and its surrounding industrial areas form an important part of Gujarat’s healthcare and pharmaceutical ecosystem.
Sarian Healthcare serves healthcare professionals, hospitals, distributors, stockists, pharmacies, clinics, and procurement teams through its pharmaceutical product portfolio.
Pharma Distributors and Wholesale Supply
ARIPRIDE-80 INJ is part of Sarian Healthcare’s pharmaceutical portfolio for professional healthcare and pharmaceutical supply channels.
Distributors, stockists, hospitals, pharmacies, clinics, and pharmaceutical procurement teams can contact Sarian Healthcare for product availability, commercial information, and supply-related enquiries.
For businesses searching for pharma distributors, pharmaceutical suppliers, or wholesale pharmaceutical products, Sarian Healthcare provides a structured portfolio for professional pharmaceutical procurement.
Medicine Manufacturing Company in Ahmedabad
Sarian Healthcare is associated with the pharmaceutical manufacturing and supply ecosystem serving Ahmedabad and Gujarat.
Its product portfolio includes pharmaceutical formulations across multiple therapeutic categories and dosage forms, supporting healthcare professionals and pharmaceutical distribution networks.
Why Choose Sarian Healthcare as a Reliable Pharmaceutical Partner?
Sarian Healthcare focuses on maintaining a reliable pharmaceutical portfolio supported by professional product development and supply practices.
Key aspects include:
- Diverse pharmaceutical portfolio across multiple therapeutic categories
- Multiple dosage forms for different healthcare requirements
- Quality-focused pharmaceutical processes
- Professional product information for healthcare and procurement teams
- Support for distributors and stockists
- Pharmaceutical supply across healthcare channels
- Focus on consistent product availability
- Growing presence within Gujarat’s pharmaceutical ecosystem
- Professional approach to pharmaceutical product development and distribution
For doctors, pharmacists, hospitals, distributors, stockists, clinics, and pharmaceutical procurement teams, Sarian Healthcare provides a portfolio designed to support professional healthcare supply requirements.
Sarian Healthcare – Growing Pharmaceutical Partner in India
Sarian Healthcare continues to develop its pharmaceutical product portfolio across multiple therapeutic areas and dosage forms.
The company’s focus on pharmaceutical products, supply capabilities, and professional healthcare partnerships supports its growing presence within India’s pharmaceutical sector.
With products such as ARIPRIDE-80 INJ, Sarian Healthcare provides a defined Methylprednisolone Acetate injectable presentation for professional healthcare requirements.
ARIPRIDE-80 INJ – Product Summary
ARIPRIDE-80 INJ contains Methylprednisolone Acetate 80 mg/mL and is supplied as a 1 × 2 mL vial.
Methylprednisolone Acetate is a glucocorticoid corticosteroid with anti-inflammatory and immunomodulatory activity. It acts through intracellular glucocorticoid receptors to influence inflammatory gene expression and suppress multiple inflammatory pathways.
The product is manufactured by Sarian Healthcare and should be administered only by a qualified healthcare professional.
The appropriate dose, route, frequency, and treatment duration depend on the clinical condition and physician’s assessment. The supplied product information specifically states that the injectable suspension must not be administered intrathecally.









